GC
SNY icon

Gould Capital’s Sanofi SNY Stock Holding History

Gould Capital’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-307
Closed -$14.8K – 222
2024
Q4 		$14.8K Hold
307
– – 0.01% 126
2024
Q3 		$17.7K Sell
307
-20,715
-99% -$1.12M 0.01% 133
2024
Q2 		$1.02M Buy
21,022
+744
+4% +$35.9K 0.72% 39
2024
Q1 		$986K Buy
20,278
+2,178
+12% +$106K 0.69% 41
2023
Q4 		$900K Sell
18,100
-172
-0.9% -$8.41K 0.66% 40
2023
Q3 		$979K Buy
18,272
+142
+0.8% +$7.57K 0.79% 33
2023
Q2 		$977K Sell
18,130
-354
-2% -$19K 0.75% 35
2023
Q1 		$1.01M Buy
+18,484
New +$899K 0.78% 31

Other funds holding SNY

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Gould Capital's SNY Position: Q1 2025 in Review

Gould Capital sold out of Sanofi (SNY) in Q1 2025, closing a stake of 307 shares — an estimated $14.8K sold.

Gould Capital first reported a position in SNY in Q1 2023 and held it in 8 quarters. The position peaked at $1.02M in Q2 2024. 771 funds tracked by Wall St. Rank hold SNY as of Q1 2025.

  • Gould Capital reported no remaining Sanofi position as of Q1 2025 after selling out during the quarter.
  • Gould Capital sold 307 Sanofi shares in Q1 2025, an estimated $14.8K.
  • Gould Capital first reported a position in Sanofi in Q1 2023 and held it in 8 quarters.
  • Gould Capital's Sanofi position peaked at $1.02M in Q2 2024.
  • 771 funds tracked by Wall St. Rank held Sanofi as of Q1 2025.

Based on Gould Capital's 13F filing for Q1 2025, filed 14 May 2025.